Article History
Received: 10 September 2020
Accepted: 25 September 2020
First Online: 14 October 2020
Compliance with ethical standards
:
: FGZ has received grants for investigator-initiated clinical trials from Bactiguard, Sweden, and Ionis Pharmaceuticals, USA, in the past 5 years. FGZ has also received grants from the Brazilian Ministry of Health to conduct research, including observational studies, in Brazil through the Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS). FGZ has not received direct compensation, travel support, or holds stock market shares from any pharmaceutical company. Markus B Skrifvars has received travel grants and speaker’s fees from BARD Medical (Ireland) and a research grant from GE Healthcare. JA has no conflicts of interest to declare.
Free to read: This content has been made available to all.